Table of Contents Author Guidelines Submit a Manuscript
International Journal of Breast Cancer
Volume 2018 (2018), Article ID 1426369, 7 pages
https://doi.org/10.1155/2018/1426369
Research Article

The Use of Sentinel Lymph Node Biopsy in BRCA1/2 Mutation Carriers Undergoing Prophylactic Mastectomy: A Retrospective Consecutive Case-Series Study

1Department of Gynecology and Obstetrics, Hospital Dr. Nélio Mendonça, Avenida Luís de Camões, No. 57, 9004-514 Funchal, Portugal
2Department of Pathology, Instituto Português de Oncologia Francisco Gentil (IPOLFG), Lisbon, Portugal
3Department of Breast Cancer Risk Evaluation Clinic and Department of Medical Oncology, Instituto Português de Oncologia Francisco Gentil (IPOLFG), Lisbon, Portugal
4Department of Surgical Oncology, Instituto Português de Oncologia Francisco Gentil (IPOLFG), Lisbon, Portugal
5Radiology Department, Instituto Português de Oncologia Francisco Gentil (IPOLFG), Lisbon, Portugal

Correspondence should be addressed to Sara Câmara; moc.liamg@aramac.mac.aras

Received 16 September 2017; Accepted 26 November 2017; Published 1 January 2018

Academic Editor: Vladimir F. Semiglazov

Copyright © 2018 Sara Câmara et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. M. Tuttle, S. Jarosek, E. B. Habermann et al., “Increasing rates of contralateral prophylactic mastectomy among patients with ductal carcinoma in situ,” Journal of Clinical Oncology, vol. 27, no. 9, pp. 1362–1367, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. E. B. Habermann, A. Abbott, H. M. Parsons, B. A. Virnig, W. B. Al-Refaie, and T. M. Tuttle, “Are mastectomy rates really increasing in the United States?” Journal of Clinical Oncology, vol. 28, no. 21, pp. 3437–3441, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. V. Murthy and R. S. Chamberlain, “Prophylactic mastectomy in patients at high risk: Is there a role for sentinel lymph node biopsy?” Clinical Breast Cancer, vol. 13, no. 3, pp. 180–187, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. A. C. Antoniou, W. D. Foulkes, and M. Tischkowitz, “Breast-cancer risk in families with mutations in PALB2: The authors reply,” The New England Journal of Medicine, vol. 371, no. 17, pp. 1651-1652, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. R. Wooster and B. L. Weber, “Breast and ovarian cancer,” The New England Journal of Medicine, vol. 348, no. 23, pp. 2339–2347, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. D. G. Evans, J. Wisely, T. Clancy et al., “Longer term effects of the Angelina Jolie effect: Increased risk-reducing mastectomy rates in BRCA carriers and other high-risk women,” Breast Cancer Research, vol. 17, no. 1, article no. 143, 2015. View at Publisher · View at Google Scholar · View at Scopus
  7. L. C. Hartmann and N. M. Lindor, “The role of risk-reducing surgery in hereditary breast and ovarian cancer,” The New England Journal of Medicine, vol. 374, no. 5, pp. 454–468, 2016. View at Publisher · View at Google Scholar · View at Scopus
  8. X. Li, R. You, X. Wang et al., “Effectiveness of prophylactic surgeries in BRCA1 or BRCA2 mutation carriers: A meta-analysis and systematic review,” Clinical Cancer Research, vol. 22, no. 15, pp. 3971–3981, 2016. View at Publisher · View at Google Scholar · View at Scopus
  9. L. Lostumbo, N. E. Carbine, and J. Wallace, “Prophylactic mastectomy for the prevention of breast cancer,” Cochrane Database of Systematic Reviews, vol. 11, Article ID CD002748, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Burger, D. Thurtle, S. Owen et al., “Sentinel lymph node biopsy for risk-reducing mastectomy,” The Breast Journal, vol. 19, no. 5, pp. 529–532, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. C. L. Miller, M. C. Specht, M. N. Skolny et al., “Sentinel lymph node biopsy at the time of mastectomy does not increase the risk of lymphedema: Implications for prophylactic surgery,” Breast Cancer Research and Treatment, vol. 135, no. 3, pp. 781–789, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. L. G. Wilke, L. M. McCall, K. E. Posther et al., “Surgical complications associated with sentinel lymph node biopsy: Results from a prospective international cooperative group trial,” Annals of Surgical Oncology, vol. 13, no. 4, pp. 491–500, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Fleissig, L. J. Fallowfield, C. I. Langridge et al., “Post-operative arm morbidity and quality of life. Results of the ALMANAC randomised trial comparing sentinel node biopsy with standard axillary treatment in the management of patients with early breast cancer,” Breast Cancer Research and Treatment, vol. 95, no. 3, pp. 279–293, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Lucci, L. M. McCall, P. D. Beitsch et al., “Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group trial Z0011,” Journal of Clinical Oncology, vol. 25, no. 24, pp. 3657–3663, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. McLaughlin, “Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: Objective measurements (Journal of Clinical Oncology (2008) 26 (5213-5219)),” Journal of Clinical Oncology, vol. 28, no. 10, p. 1808, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. V. Nagaraja, S. Edirimanne, and G. D. Eslick, “Is sentinel lymph node biopsy necessary in patients undergoing prophylactic mastectomy? a systematic review and meta-analysis,” The Breast Journal, vol. 22, no. 2, pp. 158–165, 2016. View at Publisher · View at Google Scholar · View at Scopus
  17. I. A. Czyszczon, L. Roland, and S. Sahoo, “Routine prophylactic sentinel lymph node biopsy is not indicated in women undergoing prophylactic mastectomy,” Journal of Surgical Oncology, vol. 105, no. 7, pp. 650–654, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. W.-B. Zhou, X.-A. Liu, J.-C. Dai, and S. Wang, “Meta-analysis of sentinel lymph node biopsy at the time of prophylactic mastectomy of the breast,” Canadian Journal of Surgery, vol. 54, no. 5, pp. 300–306, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. J. C. Boughey, J. N. Cormier, Y. Xing et al., “Decision analysis to assess the efficacy of routine sentinel lymphadenectomy in patients undergoing prophylactic mastectomy,” Cancer, vol. 110, no. 11, pp. 2542–2550, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. E. L. Dupont, M. A. Kuhn, C. McCann, C. Salud, J. L. Spanton, and C. E. Cox, “The role of sentinel lymph node biopsy in women undergoing prophylactic mastectomy,” The American Journal of Surgery, vol. 180, no. 4, pp. 274–277, 2000. View at Publisher · View at Google Scholar · View at Scopus
  21. C. Laronga, M. C. Lee, K. P. McGuire et al., “Indications for Sentinel Lymph Node Biopsy in the Setting of Prophylactic Mastectomy,” Journal of the American College of Surgeons, vol. 209, no. 6, pp. 746–752, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. D. Black, M. Specht, J. M. Lee et al., “Detecting occult malignancy in prophylactic mastectomy: Preoperative MRI versus sentinel lymph node biopsy,” Annals of Surgical Oncology, vol. 14, no. 9, pp. 2477–2484, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. A. Soran, J. Falk, M. Bonaventura, D. Keenan, G. Ahrendt, and R. Johnson, “Is routine sentinel lymph node biopsy indicated in women undergoing contralateral prophylactic mastectomy? Magee-Womens Hospital experience,” Annals of Surgical Oncology, vol. 14, no. 2, pp. 646–651, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. T. A. King, A. Ganaraj, J. V. Fey et al., “Cytokeratin-positive cells in sentinel lymph nodes in breast cancer are not random events: Experience in patients undergoing prophylactic mastectomy,” Cancer, vol. 101, no. 5, pp. 926–933, 2004. View at Publisher · View at Google Scholar · View at Scopus
  25. P. W. Bunting, A. E. Cyr, F. Gao, and J. A. Margenthaler, “Sentinel lymph node biopsy during prophylactic mastectomy: Is there a role?” Journal of Surgical Oncology, vol. 109, no. 8, pp. 747–750, 2014. View at Publisher · View at Google Scholar · View at Scopus
  26. J. C. Boughey, N. Khakpour, F. Meric-Bernstam et al., “Selective use of sentinel lymph node surgery during prophylactic mastectomy,” Cancer, vol. 107, no. 7, pp. 1440–1447, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology, “Breast Cancer Screening and Diagnosis,” https://www.nccn.org/professionals/physician_gls/pdf/breast-screening.pdf.
  28. National institue for Health and Care Excellence, “Clinical guideline on Familial breast cancer: classification, care and managing breast cancer and related risks in people with a family history of breast cancer,” 2013, https://www.nice.org.uk/guidance/cg164.
  29. V. Freitas, P. Crystal, S. R. Kulkarni et al., “The value of breast MRI in high-risk patients with newly diagnosed breast cancer to exclude invasive disease in the contralateral prophylactic mastectomy: Is there a role to choose wisely patients for sentinel node biopsy?” Cancer Medicine, vol. 5, no. 6, pp. 1031–1036, 2016. View at Publisher · View at Google Scholar · View at Scopus
  30. S. A. McLaughlin, M. Stempel, E. A. Morris, L. Liberman, and T. A. King, “Can magnetic resonance imaging be used to select patients for sentinel lymph node biopsy in prophylactic mastectomy?” Cancer, vol. 112, no. 6, pp. 1214–1221, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. N. K. Kuwajerwala, N. S. Dekhne, P. A. Pentiak et al., “Sentinel lymph node biopsy in contralateral prophylactic mastectomy: are we overtreating? Experience at a tertiary care hospital,” Clinical Breast Cancer, vol. 13, no. 4, pp. 287–291, 2013. View at Publisher · View at Google Scholar · View at Scopus
  32. S. M. Nasser, S. G. Smith, and A. B. Chagpar, “The role of sentinel node biopsy in women undergoing prophylactic mastectomy,” Journal of Surgical Research, vol. 164, no. 2, pp. 188–192, 2010. View at Publisher · View at Google Scholar · View at Scopus